Surgical experience of adult primary hepatic sarcomas

Table 1 The demographics, histology, surgical procedures, and survival of the patients

	Sex	Age	Preoperative biopsy	Pathology	Size (cm)	Operation	Recurrence (months)	Follow-up (months)
1	M	46		Angiosarcoma	14	Right lobectomy	26.3	E 44.2
2	M	54	Angiosarcoma	Angiosarcoma	10	Right lobectomy	4.78	E 9.1
3	M	70		Angiosarcoma	2.5	Left lobectomy + PEI to S8	2.34	E 3.5
4	M	68	Sarcoma	Angiosarcoma	16	Right lobectomy	22.89	E 31.4
5	F	60	Angiosarcoma	Angiosarcoma	2.5	Nil		E 8.7
6	M	46	Angiosarcoma	Angiosarcoma	14	Nil		E 2.7
7	F	27		Embryonal sarcoma	14	Right lobectomy^b		A 142.5
8	M	39		Leiomyosarcoma	0.6	Right + partial S1-2^a	1.0	E 33.7
9	F	39	Neuroendocrine tumor	HEHE	2.7	Deceased donor LT^a		A 135.9
10	F	21		Undifferentiated sarcoma	5	S4 resection + resection of solitary lung metastasis^b		A 123.7
11	M	69	Malignant spindle cell neoplasm	Undifferentiated sarcoma	15.5	Left lobectomy^b	3.7	E 8.2
12	M	49	Negative	Malignant mesenchymoma	4.5	Living donor LT	5.6	E 19.4
13	F	61		Undifferentiated sarcoma	16	Right lobectomy		A 65.4

HEHE hepatic epithelioid hemangioendothelioma, PEI percutaneous ethanol injection, LT liver transplantation, A alive, E expired, S8 segment 8 of liver, S1-2 segment 1 and 2 of liver, S4 segment 4 of liver.
^aPreoperative TAE; ^badjuvant chemotherapy.

ISSN: 1477-7819